![Michael Schaeffer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: - $ in data 30/06/2026
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
Crelux GmbH
 Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Amministratore Delegato | 01/03/2016 |
SiREEN AG
 SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Amministratore Delegato | 01/01/2004 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
SiREEN AG
SiREEN AG Miscellaneous Commercial ServicesCommercial Services Researches and discovers drugs specializing in diseases such as colon cancer and immune tolerance | Commercial Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vivoryon Therapeutics NV
 Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Provides drug discovery services | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
